secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001193125-23-096599
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks appoints Derek Miller to board of directors
-----------------------------------------------------

- Appointed as Class II director, term expiring at 2023 annual meeting.
- Received initial stock option grant for 50,000 shares of common stock.
- Over 25 years biotech experience, former CBO of Celator and Aro Biotherapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312523096599/0001193125-23-096599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312523096599/d495408d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-096599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer